Clinical trials
Withdrawn Leukemia, Myelomonocytic, Chronic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 3 |
| 2012 | 1 |
| 2017 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 4 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 22 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 4 |
| Fred Hutchinson Cancer Center | 2 |
| Alliance for Clinical Trials in Oncology | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Indiana University | 1 |
| Janssen Research & Development, LLC | 1 |
| Jonsson Comprehensive Cancer Center | 1 |
| Mayo Clinic | 1 |
| Racura Oncology Ltd | 1 |
| Rhizen Pharmaceuticals SA | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myelomonocytic, Chronic | 22 |
| Leukemia, Myeloid, Acute | 16 |
| Myelodysplastic Syndromes | 16 |
| Myeloproliferative Disorders | 13 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 13 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 12 |
| Lymphoma, Non-Hodgkin | 12 |
| Lymphoma, B-Cell, Marginal Zone | 11 |
| Lymphoma, Follicular | 11 |
| Lymphoma, Mantle-Cell | 11 |
Trials
Showing 51 to 22 of 22. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.